on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. recently submitted a Form 8.3 disclosing its interests in Spire Healthcare Group plc securities. The form, dated 17 November 2025, outlines Vanguard's position as required under Rule 8.3 of the Takeover Code. The disclosure details Vanguard's holding of 14,372,647 ordinary shares, representing 3.57% of Spire Healthcare's relevant securities.
The filing indicates the transactions dated 14 November 2025, and includes specific dealings of Vanguard's buying and selling activities. A purchase of 2,058 ordinary shares and a sale of 12,510 shares at a price of 2.25 GBP per unit were reported.
No cash-settled or stock-settled derivatives or additional agreements related to options or voting rights were disclosed. There are no attachments or further agreements stated. This transparent disclosure allows for a public understanding of Vanguard's stake in Spire Healthcare.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news